Orally administered recombinant Lactobacillus expressing African swine fever virus antigens that induced immunity responses
- PMID: 36699597
- PMCID: PMC9869048
- DOI: 10.3389/fmicb.2022.1103327
Orally administered recombinant Lactobacillus expressing African swine fever virus antigens that induced immunity responses
Erratum in
-
Corrigendum: Orally administered recombinant Lactobacillus expressing African swine fever virus antigens that induced immunity responses.Front Microbiol. 2024 Dec 3;15:1529166. doi: 10.3389/fmicb.2024.1529166. eCollection 2024. Front Microbiol. 2024. PMID: 39691912 Free PMC article.
Abstract
African swine fever (ASF) is a highly contagious, acute, febrile disease caused by the African swine fever virus (ASFV), with morbidity and mortality rates approaching 100% in domestic and wild swine, resulting in massive economic losses to the pig industry worldwide. This study aimed to express the p30, p54, and p72 proteins encoded by ASFV in vitro using the Lactobacillus lactis (L. lactis) expression system. Here, six new functional recombinant L. lactis were constructed, and the expression of the p30 protein, p54 protein, p72 protein, p30-LTB (heat-labile enterotoxin B, LTB) fusion protein, p54-LTB fusion protein, and the p72-LTB fusion protein was successfully detected by Western blot analysis. Following oral immunization of rabbits with recombinant L. lactis, serum IgG, intestinal mucosal sIgA, cytokines (IL-4 and INF-γ), and splenocyte viability were higher than in the control group via ELISA. Notably, without the LTB adjuvant group, humoral and Th1 cellular immunity were promoted, whereas, with the LTB adjuvant group, local mucosal immunity, humoral immunity, and Th2 cellular immunity were promoted, providing new insights into the design and development of an ASFV subunit vaccine.
Keywords: African swine fever virus; Lactococcus lactis; enterotoxin B subunit; immunogenicity evaluation; oral immunization; recombinant expression.
Copyright © 2023 Zhang, Zhao, Zhang, Shen, Zhang, Shan and Cai.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Mucosal and cellular immune responses elicited by nasal and intramuscular inoculation with ASFV candidate immunogens.Front Immunol. 2023 Sep 1;14:1200297. doi: 10.3389/fimmu.2023.1200297. eCollection 2023. Front Immunol. 2023. PMID: 37720232 Free PMC article.
-
Evaluation of the Immunogenicity of a Pool of Recombinant Lactococcus lactis Expressing Eight Antigens of African Swine Fever Virus in a Mouse Model.Vet Sci. 2025 Feb 7;12(2):140. doi: 10.3390/vetsci12020140. Vet Sci. 2025. PMID: 40005900 Free PMC article.
-
Evaluation of humoral and cellular immune responses induced by a cocktail of recombinant African swine fever virus antigens fused with OprI in domestic pigs.Virol J. 2023 May 26;20(1):104. doi: 10.1186/s12985-023-02070-7. Virol J. 2023. PMID: 37237390 Free PMC article.
-
Antigenicity and immunogenicity of recombinant proteins comprising African swine fever virus proteins p30 and p54 fused to a cell-penetrating peptide.Int Immunopharmacol. 2021 Dec;101(Pt A):108251. doi: 10.1016/j.intimp.2021.108251. Epub 2021 Oct 29. Int Immunopharmacol. 2021. PMID: 34715492
-
Regulation of antiviral immune response by African swine fever virus (ASFV).Virol Sin. 2022 Apr;37(2):157-167. doi: 10.1016/j.virs.2022.03.006. Epub 2022 Mar 9. Virol Sin. 2022. PMID: 35278697 Free PMC article. Review.
Cited by
-
Vaccines for African swine fever: an update.Front Microbiol. 2023 Apr 27;14:1139494. doi: 10.3389/fmicb.2023.1139494. eCollection 2023. Front Microbiol. 2023. PMID: 37180260 Free PMC article. Review.
-
Recent progress and major gaps in the vaccine development for African swine fever.Braz J Microbiol. 2024 Mar;55(1):997-1010. doi: 10.1007/s42770-024-01264-7. Epub 2024 Feb 5. Braz J Microbiol. 2024. PMID: 38311710 Free PMC article. Review.
-
Advancement in the Antigenic Epitopes and Vaccine Adjuvants of African Swine Fever Virus.Pathogens. 2024 Aug 21;13(8):706. doi: 10.3390/pathogens13080706. Pathogens. 2024. PMID: 39204306 Free PMC article. Review.
-
Progress in African Swine Fever Vector Vaccine Development.Int J Mol Sci. 2025 Jan 22;26(3):921. doi: 10.3390/ijms26030921. Int J Mol Sci. 2025. PMID: 39940691 Free PMC article. Review.
-
Navigating the threat of African swine fever: a comprehensive review.Trop Anim Health Prod. 2024 Sep 24;56(8):278. doi: 10.1007/s11250-024-04129-1. Trop Anim Health Prod. 2024. PMID: 39316231 Review.
References
-
- Aliramaei M. R., Khorasgani M. R., Rahmani M. R., Zarkesh Esfahani S. H., Emamzadeh R. (2019). Expression of Helicobacter pylori CagL gene in Lactococcus lactis MG1363 and evaluation of its immunogenicity as an oral vaccine in mice. Microb. Pathog. 142:103926. doi: 10.1016/j.micpath.2019.103926, PMID: - DOI - PubMed
LinkOut - more resources
Full Text Sources